课题基金 / 基金详情

CD8 T cell and B cell collaboration following subunit vaccination

CD8 T cell and B cell collaboration following subunit vaccination
亚单位疫苗接种后 CD8 T 细胞和 B 细胞协作
批准号:
10055979
负责人:
Ross M Kedl
金额:
$52.42万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-19 至 2024-07-31

项目摘要

项目成果

Ross M Kedl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Some of the most successful vaccines to date, including those against the deadly viruses small pox, measles, mumps, and rubella, comprise attenuated viral particles, capable of inducing both humoral and cellular immunity. However, because protection through live infection is not feasible for many pathogens, including HIV, malaria, tuberculosis, and cancer, alternative vaccine approaches are needed. A single immunization with a protein subunit antigen and a combination of agonists toward pattern recognition receptors and CD40 (combined-adjuvant subunit vaccine) generates a magnitude of CD8+ and CD4+ T cell responses that is exponentially larger than those typically induced by viral vectors in both mice and non-human primates. Given the clinical promise of this vaccine platform, the careful study of the mechanisms controlling its potency may uncover novel targets for the development of more effective prophylactic and therapeutic vaccines. Over the past decade, studies of immunization and infection have revealed shared and distinct pathways utilized in the generation of immunological memory. We have documented a unique metabolic program used by expanding vaccine-elicited T cells, and requirements for cytokines (IL-15, IL-27) and transcription factors (Tbet, Eomes) that are dispensable for the expansion of infection-elicited T cells. These discrepancies led us to question other factors previously thought to be unimportant for the generation of CD8+ T cell responses, such as the concurrent activation and proliferation of antigen-specific B cells. Given the disproportionate expansion of B cells very early following subunit immunization, it seemed plausible that B cells could provide costimulatory support for the ensuing CD8+ T cell response, either directly, or indirectly. Preliminary data support this unconventional proposition. In fact, preliminary data also show that CD8+ T cell responses likewise benefit the antibody response to subunit vaccination. We do not yet understand the underlying mechanisms that integrate B cells and CD8+ T cells for the generation of long-lived cellular and humoral immunity. Our proposal will use classic immunological approaches to fully elucidate, specific to the context of subunit vaccination, 1) the role of B cell antigen presentation and cytokine production in the regulation of CD8+ T cell survival and cell fate determination, 2) the role of B cells in CD8+ T cell memory formation and maintenance, and 3) the mechanisms by which antigen- specific CD8+ T cells influence B cell activation and antibody formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
  • 批准号:
    10508093
  • 项目类别:
  • 资助金额:
    $23.33万
  • 财政年份:
    2022
  • 负责人:
    Ross M Kedl
  • 依托单位:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
  • 批准号:
    10662571
  • 项目类别:
  • 资助金额:
    $19.44万
  • 财政年份:
    2022
  • 负责人:
    Ross M Kedl
  • 依托单位:
Exploring the heterogeneity of the vaccine-elicited T cell response by scRNAseq
  • 批准号:
    10334559
  • 项目类别:
  • 资助金额:
    $19.44万
  • 财政年份:
    2021
  • 负责人:
    Ross M Kedl
  • 依托单位:
Exploring the heterogeneity of the vaccine-elicited T cell response by scRNAseq
  • 批准号:
    10218805
  • 项目类别:
  • 资助金额:
    $23.33万
  • 财政年份:
    2021
  • 负责人:
    Ross M Kedl
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: